SVA
Sinovac Biotech Ltd
6.50$
+0.0%
vs. previous close
Closing price · As of: Sep 12, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q4 23 | Q2 24 | Q4 24 | Q2 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 87.1% | 85.9% | 85.9% | – | 85.7% | 86.6% | 86.4% | 86.3% | 86.6% | 82.7% | 82.7% | 81.4% | |
| 45.5% | 30.3% | 30.3% | – | 12.0% | 9.3% | 8.3% | 2.7% | 1.5% | 5.7% | 5.7% | 4.0% | |
| 78.6% | 80.1% | 80.1% | – | 80.6% | 82.2% | 82.0% | – | – | – | 69.9% | – | |
| 6.4% | 4.3% | 4.3% | – | 3.6% | 3.3% | 3.1% | 2.4% | 2.6% | 3.4% | 3.7% | 3.3% | |
| 1.8% | 1.3% | 1.3% | – | 1.3% | 1.0% | 1.2% | 0.8% | 0.9% | 1.1% | 1.1% | 1.3% | |
| – | 2.4% | – | – | – | – | – | 0.2% | 0.1% | 0.1% | 0.1% | 0.2% | |
| 0.3% | 0.6% | 0.6% | – | 0.5% | 0.5% | 0.5% | 1.5% | 1.1% | 1.6% | 1.6% | 1.7% | |
| 6.5% | 9.9% | 9.9% | – | 10.8% | 12.0% | 10.8% | 16.6% | 47.1% | 25.1% | 25.1% | 20.6% | |
| 3.7% | 7.7% | 7.7% | – | 8.7% | 8.4% | 7.6% | 11.8% | 41.7% | 18.0% | 18.0% | 13.4% | |
| 0.1% | 0.1% | 0.1% | – | 1.5% | 0.6% | 1.4% | – | – | – | 2.7% | – | |
| 2.2% | 0.1% | 6.4% | – | 6.0% | 0.1% | 5.0% | 0.1% | 4.9% | 0.2% | 0.2% | 3.1% | |
| – | – | 0.1% | – | 0.1% | 1.3% | 1.0% | 1.3% | 1.9% | 3.1% | – | 2.9% | |
| 62.8% | 63.2% | 63.2% | – | 63.1% | 63.8% | 67.1% | 67.0% | 36.5% | 52.0% | 52.0% | 55.4% | |
| 50.6% | 51.2% | 51.2% | – | 52.8% | 52.1% | 55.1% | 55.4% | 23.8% | 33.0% | 33.0% | 33.9% | |
| 0.8% | 0.7% | 0.7% | 0.8% | 0.8% | 0.7% | 0.6% | 0.6% | 0.6% | 0.8% | – | 0.9% |
Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.